Steven P Balk

39PUBLICATIONS
212CO-AUTHORS
Genome structure and regulationPredictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (39)

|Sep 09, 2026
Minimal-length CAG repeats in AR define a hyperactive AR-LSD1 axis driving metabolic reprogramming in prostate cancer.

|May 27, 2026
RNAs anchoring replication complex control initiation and firing of DNA replication.

|May 11, 2026
Immune Spatial Organization Predicts Distant Metastasis Risk in Aggressive Localized Prostate Cancer.

|Feb 14, 2026
FOXJ1 mediates taxane resistance through regulation of microtubule dynamics.

Fang Xie, Ada Gjyrezi, Daniel Fein

|Jan 27, 2026
Lack of synergy between AR-targeted therapies and PARP inhibitors in homologous recombination-proficient prostate cancer.

Nicole A Traphagen, Esmé Wheeler, Rong Li

|Oct 08, 2025
Elucidating molecularly stratified single agent, and combination, therapeutic strategies targeting MCL1 for lethal prostate cancer.

Juan M Jiménez-Vacas, Daniel Westaby, Ines Figueiredo

Pageof 7

Frequent Collaborators

11 joint publications

David J Einstein

9 joint publications

Adam G Sowalsky

8 joint publications

Seiji Arai

7 joint publications

Joshua W Russo